Radionuclide imaging

Radionuclide imaging is a diagnostic technique that uses radioactive substances to visualize and functionally assess the physiology of the body. It is a part of nuclear medicine and includes techniques such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT).

Overview

Radionuclide imaging involves the administration of a radiopharmaceutical to the patient, which then emits gamma rays. These gamma rays are detected by a special camera, which produces an image that reflects the distribution of the radiopharmaceutical within the body. This allows for the visualization of organ function and structure, and can be used to diagnose a variety of conditions.

Procedure

The procedure for radionuclide imaging varies depending on the specific test being performed. However, in general, the patient is injected with a radiopharmaceutical, which travels through the body and accumulates in the organ or tissue being examined. The gamma rays emitted by the radiopharmaceutical are then detected by a gamma camera, which produces an image.

Applications

Radionuclide imaging is used in a variety of medical fields, including cardiology, oncology, and neurology. It can be used to diagnose conditions such as cancer, heart disease, and brain disorders, as well as to monitor the effectiveness of treatments.

Risks

While radionuclide imaging is generally safe, there are some risks associated with the procedure. These include allergic reactions to the radiopharmaceutical, and exposure to radiation. However, the benefits of the procedure generally outweigh these risks.

See also

• Nuclear medicine
• Radiopharmaceutical
• Gamma camera

Radionuclide imaging Resources
Latest articles Most recent articles Ongoing trials	Wikipedia